Connect with us

Published

on

Blocked from the U.S. by tariffs, Chinese electric vehicle makers have looked elsewhere to sell their high-tech cars. But as Mexico has emerged as a hot spot for Chinese EVs, Washington officials worry the country may be used as a “backdoor” to the U.S. market.  

Last year, China was the leading car supplier to Mexico, exporting $4.6 billion worth of vehicles to the country, according to the Mexican Ministry of Economy. Even customers wary of EVs have been won over by affordable price tags. Tesla rival BYD sells its Dolphin Mini in Mexico for around 398,800 pesos, or about $21,300, a little over half the price of the cheapest Tesla. 

“The Chinese automakers came to the country very aggressively,” said Juan Carlos Baker, former Mexican deputy minister for international trade. “They have very good promotions. It’s a good product that sells at a very reasonable price.” 

Some Chinese EV makers, including BYD, have been looking for a further foothold in North America by exploring factory sites in the Mexican states of Durango, Jalisco and Nuevo Leon. The foreign investment would be an economic boost for Mexico. BYD has claimed that a plant there would create around 10,000 jobs.  

But U.S. officials worry this could be a part of a larger strategy by Chinese automakers to skirt trade restrictions and enter the American market.  

“Mexico is an attractive production platform, not only for Chinese companies, but for other companies as well, in part because of that free trade access that it has to the American market,” said Scott Paul, president of the Alliance for American Manufacturing. “And it can do something that in trade terms is called circumvention.” 

That free trade access is part of the United States-Mexico-Canada Agreement (USMCA), a revised iteration of the North American Free Trade Agreement (NAFTA) that removed tariffs on many goods traded between the North American countries starting in 2018. Under the agreement, if a foreign auto company manufactures in either Canada or Mexico and can prove that the building materials are sourced locally, the goods can be exported to the U.S. virtually duty-free.  

“We’ve seen China do this in other types of manufacturing as well, from appliances to auto parts to steel,” said Paul. “For more than a decade now, China, the United States have been playing a high-stakes game of whack-a-mole when it comes to trade policy tariffs.”

While meeting the USMCA requirements is difficult, the potential scenario terrifies U.S. lawmakers and auto companies.

“If [Chinese EV makers] are able to set up in Mexico, they would definitely pose an imminent threat to American automakers, if for no other reason, because their costs would be lower,” said Michael Dunne, CEO of Dunne Insights.  

In May, President Joe Biden announced a 100% tariff on Chinese EVs.

“We [the U.S.] are just starting to scale up our EV industry, so it’s what I call an ‘infant industry,'” said Paul. “And like any infant, it’s at a very delicate time in terms of development and has to be massively protected.” 

Experts say pressure from the U.S. leaves Mexico in a difficult position of maintaining its crucial relationship with America without being overly friendly to Chinese investment.  

Watch the video to learn more about how Mexico has become a hot spot for Chinese auto companies and how the next administration may impact EV trade policies.  

Continue Reading

Technology

World’s largest chipmaker TSMC says it has discovered potential trade secret leaks

Published

on

By

World's largest chipmaker TSMC says it has discovered potential trade secret leaks

TSMC workers walk down a hallway in a chipmaking fab in Taiwan. The company is building three such plants in Arizona.

TSMC

Taiwan Semiconductor Manufacturing Co. said on Tuesday that it had detected “unauthorized activities” that lead to the discovery of potential trade secret leaks.

The world’s biggest semiconductor manufacturer told CNBC that it has taken “strict” disciplinary action against the personnel involved and that it has also launched legal proceedings.

“TSMC maintains a zero-tolerance policy toward any actions that compromise the protection of trade secrets or harm the company’s interests,” the company said.

“Such violations are dealt with strictly and pursued to the fullest extent of the law. We remain committed to safeguarding our core competitiveness and the shared interests of all our employees.”

Semiconductors have grown in strategic importance in recent years as they have become the key pillar in the boom in artificial intelligence models and applications. Rising geopolitical tensions has put the spotlight on the competitive technological advantages of major firms in the chip supply chain like TSMC and other leaders across the board.

TSMC, headquartered in Taiwan, dominates the market for the manufacturing of the world’s most advanced chips and counts major tech giants including Apple and Nvidia as clients.

As the case is now under judicial review, TSMC is unable to provide further information, the firm said.

TSMC identified the issue early due to its “comprehensive and robust monitoring mechanisms,” the company said, adding that it carried out swift internal investigations.

Nikkei Asia, citing multiple sources familiar with the matter, reported on Tuesday that several former employees of TSMC are suspected of attempting to obtain critical proprietary information on 2-nanometer chip development and production while they were still working at the company.

Production of the 2-nanometer chip is among the leading edge manufacturing processes in the semiconductor industry currently. TSMC said it did not have any additional information to share when asked by CNBC about the Nikkei report.

As the world’s leading chipmaker, TSMC has a treasure trove of intellectual property. By its own account, the company has previously said it has more than 200,000 trade secrets recorded in its internal system.

It is not the first time that TSMC has been the target for potential theft. In 2018, a Taiwanese court indicted a former employee for copying trade secretes related to the 28-nanometer fabrication process, with intent to transfer them to a semiconductor company in mainland China.

In 2023, ASML, which makes machines that are required to manufacture the most advanced chips, said that it discovered that a former employee in China had misappropriated data related to its proprietary technology.

Continue Reading

Technology

Hims & Hers stock falls 10% on revenue miss

Published

on

By

Hims & Hers stock falls 10% on revenue miss

The Hers app arranged on a smartphone in New York, US, on Wednesday, Feb. 12, 2025. 

Gabby Jones | Bloomberg | Getty Images

Shares of Hims & Hers Health fell 9% in extended trading on Monday after the telehealth company reported second-quarter results that missed Wall Street’s expectations for revenue.

Here’s how the company did based on average analysts’ estimates compiled by LSEG:

  • Earnings per share: 17 cents adjusted vs. 15 cents
  • Revenue: $544.8 million vs. $552 million

Revenue at Hims & Hers increased 73% in the second quarter from $315.6 million during the same period last year, according to a release. Hims & Hers reported a net income of $42.5 million, or 17 cents per share, compared to $13.3 million, or 6 cents per share, during the same period a year earlier.

For its third quarter, Hims & Hers said it expected to report revenue between $570 million to $590 million, while analysts were expecting $583 million. The company said its adjusted EBITDA for the quarter will be between the range of $60 million to $70 million. Analysts polled by StreetAccount were expecting $77.1 million.

Read more CNBC tech news

Hims & Hers has faced controversy in recent months over its continued sale of compounded GLP-1s, which are cheaper, unapproved versions of the blockbuster diabetes and weight loss drugs. Compounded drugs can be mass produced when brand-name treatments are in shortage, but the U.S. Food and Drug Administration announced in February that ongoing supply issues had been resolved.

Some telehealth companies, including Hims & Hers, have continued to offer the compounded medications. It’s legal for patients to access personalized doses of the knockoffs in unique cases, like if they are allergic to an ingredient in a branded product, for instance. Hims & Hers has said consumers may still be able to access personalized doses through its site if clinically applicable. 

In June, Hims & Hers shares tumbled more than 30% after a short-lived collaboration with Novo Nordisk fell apart. The drugmaker said Hims & Hers “failed to adhere to the law which prohibits mass sales of compounded drugs” under the “false guise” of personalization.

Hims & Hers reported adjusted EBITDA of $82 million for its second quarter, up from $39.3 million last year and above the $73 million expected by StreetAccount.

Hims & Hers will host its quarterly call with investors at 5 p.m. ET.

Stock Chart IconStock chart icon

hide content

YTD chart of Hims & Hers Health.

–CNBC’s Annika Kim Constantino contributed to this report

Continue Reading

Technology

Palantir tops $1 billion in revenue for the first time, boosts guidance

Published

on

By

Palantir tops  billion in revenue for the first time, boosts guidance

Palantir reports $1 billion in revenue for the first time

Palantir topped Wall Street’s estimates Monday, surpassing $1 billion in quarterly revenue for the first time, and hiking its full-year guidance.

Shares rallied more than 5%.

Here’s how the company did versus LSEG estimates:

  • Earnings per share: 16 cents adj. vs. 14 cents expected
  • Revenue: $1.00 billion vs. $940 million expected

The artificial intelligence software provider’s revenues grew 48% during the period. Analysts hadn’t expected the $1 billion revenue benchmark from the Denver-based company until the fourth quarter of this year.

“The growth rate of our business has accelerated radically, after years of investment on our part and derision by some,” wrote CEO Alex Karp in a letter to shareholders. “The skeptics are admittedly fewer now, having been defanged and bent into a kind of submission.”

The software analytics company also boosted its full-year outlook guidance. For the full year, Palantir now expects revenues to range between $4.142 billion and $4.150 billion, up from prior guidance of $3.89 billion to $3.90 billion.

Read more CNBC tech news

For the third quarter, Palantir forecast revenues between $1.083 billion and $1.087 billion, beating an analyst estimate of $983 million. Palantir also lifted its operating income and full-year free cash flow guidance.

Palantir’s U.S. revenues jumped 68% from a year ago to $733 million, while U.S. commercial revenues nearly doubled from a year ago to $306 million.

The software analytics company has seen a boost from President Donald Trump‘s government efficiency campaign, which included layoffs and contract cuts. Palantir’s U.S. government revenues jumped 53% from the year-ago period to $426 million.

“It has been a steep and upward climb — an ascent that is a reflection of the remarkable confluence of the arrival of language models, the chips necessary to power them, and our software infrastructure,” Karp wrote in a letter to shareholders.

During the quarter, Palantir said it closed 66 deals of at least $5 million and 42 deals totaling at least $10 million. Total value of its contracts grew 140% from last year to $2.27 billion.

Net income rose 144% to about $326.7 million, or 13 cents a share, from about $134.1 million, or 6 cents per share a year ago.

Palantir shares have more than doubled this year as investors bet on the company’s AI tools and contract agreements with governments.

Its market value has accelerated past $379 billion and into the list of top 20 most valuable U.S companies, surpassing SalesforceIBM and Cisco to join the top 10 U.S. tech companies by market cap. Shares hit a new high Monday.

At its size, buying the stock requires investors to pay hefty multiples.

Shares currently trade 276 times forward earnings, according to FactSet. Tesla is the only other top 20 with a triple-digit ratio at 177.

Stock Chart IconStock chart icon

hide content

Palantir one-day stock chart.

Continue Reading

Trending